Posted in | News | Green Energy | Wave Power

Sarulla Consortium Signs $1.17B Funding Agreement for 330MW Geothermal Project in Indonesia

Ormat Technologies, Inc. announced today that members of the Sarulla Consortium comprising of Medco, Itochu, Kyushu and Ormat signed $1.17 billion project financing agreements to finance the development and construction of the 330-megawatt (MW) Sarulla geothermal project in Tapanuli Utara, North Sumatra in Indonesia.

Closing is expected in the second quarter of 2014 subject to fulfilment of certain conditions. Upon closing, the consortium is expected to begin construction with the first phase to commence operation in 2016. The remaining two phases are scheduled to be in commercial operation within 18 months of the first phase.

Ormat will supply its Ormat Energy Converters to the power plant and will add the $254 million supply contract to its product segment backlog once Notice to Proceed is issued, concurrently with the closing of the financing. According to the current project plan Ormat expects to recognize revenue from the project over the course of the next three to four years starting in the third quarter of 2014. In addition, Ormat, through its subsidiary Ormat International, Inc., holds a 12.75% equity stake in the Sarulla project.

These financing agreements were signed with the Japan Bank for International Cooperation (JBIC) and the Asian Development Bank (ADB), who serves as the lead structuring banks, six commercial banks (the Covered Lenders), as well as ADB in its capacity as implementing entity of the Clean Technology Fund and the Canadian Climate Fund.

The Sarulla project will obtain construction and term loans under a limited recourse financing package of direct loans from JBIC and ADB, as well as loans from the Covered Lenders backed by political risk guarantees from JBIC.

The project will be developed and implemented under a 30-year energy sales contract with Perusahaan Listrik Negara, the national electricity utility company, a 30-year joint operating contract with Pertamina Geothermal Energy, and a 20-year guarantee from the Ministry of Finance.

Dita Bronicki, chief executive officer of Ormat Technologies, said, "We are pleased to achieve this significant milestone as scheduled and look forward to continue execution on this exciting new development. We are appreciative for the hard work of the many parties that were involved in getting these agreements signed. We will continue the effort to close this financing and ultimately, supply clean, reliable electricity to the Indonesian market."

Source: http://www.ormat.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ormat Technologies, Inc. (2019, March 01). Sarulla Consortium Signs $1.17B Funding Agreement for 330MW Geothermal Project in Indonesia. AZoCleantech. Retrieved on April 19, 2024 from https://www.azocleantech.com/news.aspx?newsID=19912.

  • MLA

    Ormat Technologies, Inc. "Sarulla Consortium Signs $1.17B Funding Agreement for 330MW Geothermal Project in Indonesia". AZoCleantech. 19 April 2024. <https://www.azocleantech.com/news.aspx?newsID=19912>.

  • Chicago

    Ormat Technologies, Inc. "Sarulla Consortium Signs $1.17B Funding Agreement for 330MW Geothermal Project in Indonesia". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=19912. (accessed April 19, 2024).

  • Harvard

    Ormat Technologies, Inc. 2019. Sarulla Consortium Signs $1.17B Funding Agreement for 330MW Geothermal Project in Indonesia. AZoCleantech, viewed 19 April 2024, https://www.azocleantech.com/news.aspx?newsID=19912.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.